Source link : https://www.newshealth.biz/health-news/potassium-binder-cuts-hyperkalemia-risk-in-hf-patients-on-spironolactone/
CHICAGO — Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients with heart failure with reduced ejection fraction (HFrEF) during spironolactone optimization, a prospective, randomized-withdrawal trial showed. Among 203 patients, 71% of those taking SZC achieved the primary endpoint of optimal response — normokalemia while on at least a […]
Author : News Health
Publish date : 2024-11-20 16:57:25
Copyright for syndicated content belongs to the linked Source.